These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17958976)

  • 1. The assessment of new anti-tuberculosis drugs for a paediatric indication.
    Donald PR
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1162-5. PubMed ID: 17958976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Chapter 2: anti-tuberculosis treatment in children.
    Stop TB Partnership Childhood TB Subgroup, World Health Organization
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1205-11. PubMed ID: 17131777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and new drugs for the treatment of tuberculosis in children.
    Donald PR; Schaaf HS
    Paediatr Respir Rev; 2007 Jun; 8(2):134-41. PubMed ID: 17574157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children.
    Thee S; Detjen A; Quarcoo D; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):965-71. PubMed ID: 17705973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature.
    Trébucq A
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):12-5. PubMed ID: 9441051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities for overcoming tuberculosis: new treatment regimens.
    Freire MC
    World Hosp Health Serv; 2006; 42(1):34-7. PubMed ID: 16669375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quest for biomarkers in tuberculosis.
    Parida SK; Kaufmann SH
    Drug Discov Today; 2010 Feb; 15(3-4):148-57. PubMed ID: 19854295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TB drugs: and then there were none.
    Marshall E
    Science; 2008 Jul; 321(5887):364. PubMed ID: 18635791
    [No Abstract]   [Full Text] [Related]  

  • 10. Biomarkers for TB treatment response: challenges and future strategies.
    Walzl G; Ronacher K; Djoba Siawaya JF; Dockrell HM
    J Infect; 2008 Aug; 57(2):103-9. PubMed ID: 18649943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis: the drug development pipeline at a glance.
    Villemagne B; Crauste C; Flipo M; Baulard AR; Déprez B; Willand N
    Eur J Med Chem; 2012 May; 51():1-16. PubMed ID: 22421275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of tuberculosis in children.
    Cruz AT; Starke JR
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):939-57. PubMed ID: 19053906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of first-line drugs for treatment of tuberculosis in children: review.
    Frydenberg AR; Graham SM
    Trop Med Int Health; 2009 Nov; 14(11):1329-37. PubMed ID: 19735381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New horizons of next generation chemotherapy for mycobacteriosis].
    Doi N
    Kekkaku; 2009 Mar; 84(3):133-40. PubMed ID: 19364045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
    Ho CC; Chen YC; Hu FC; Yu CJ; Yang PC; Luh KT
    Clin Infect Dis; 2009 Jun; 48(11):1526-33. PubMed ID: 19400686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anti-tuberculosis drugs in clinical trials with novel mechanisms of action.
    Rivers EC; Mancera RL
    Drug Discov Today; 2008 Dec; 13(23-24):1090-8. PubMed ID: 18840542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR; Diacon AH
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of global capacity to conduct tuberculosis drug development trials: do we have what it takes?
    van Niekerk C; Ginsberg A
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1367-72. PubMed ID: 19861008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.